Dedong Li

Dedong Li is an experienced scientific professional with a focus on immunology and pharmacology. Currently serving as an Assistant Principal Scientist at Insmed Incorporated since March 2022, Dedong Li previously held the position of Senior Scientist. Prior experience includes a tenure as a Postdoctoral Researcher at the University of Pittsburgh, where significant contributions were made to uncovering the role of the IL-17 signaling pathway in autoimmune nephritis and elucidating GLUT1's role in neutrophil glucose uptake during infections. At Tongji University, as a Research Associate Professor, Dedong Li identified a pathogen-induced c-Cbl/RelB axis crucial for intestinal homeostasis and studied the immune responses elicited by a non-toxic Candida albicans mutant. Earlier roles include a Research Scientist and Clinical Pharmacist at the General Hospital of People's Liberation Army, focusing on optimizing antibiotic and immunomodulatory drug applications. Dedong Li's academic background includes a PhD in Pharmacology from The Second Military Medical University, alongside advanced studies at Brown University.